Estimating the risk of peripheral artery disease using different population strategies.

[1]  Y. Momiyama,et al.  Inflammation, Atherosclerosis and Coronary Artery Disease , 2014, Clinical Medicine Insights. Cardiology.

[2]  V. Aboyans,et al.  Measurement and interpretation of the ankle-brachial index: a scientific statement from the American Heart Association. , 2012, Circulation.

[3]  F. Félix-Redondo,et al.  Prevalence and clinical characteristics of peripheral arterial disease in the study population Hermex. , 2012, Revista espanola de cardiologia.

[4]  F. J. Félix-Redondo,et al.  Prevalencia y características clínicas de la enfermedad arterial periférica en la población general del estudio Hermex , 2012 .

[5]  N. Nakamura,et al.  Toe–brachial index is associated more strongly with albuminuria or glomerular filtration rate than ankle–brachial index in patients with type 2 diabetes , 2012, Hypertension Research.

[6]  F. J. Félix-Redondo,et al.  Prevalencia, detección, tratamiento y grado de control de los factores de riesgo cardiovascular en la población de Extremadura (España). Estudio HERMEX☆ , 2011 .

[7]  M. Grau,et al.  Validez relativa de la estimación del riesgo cardiovascular a 10 años en una cohorte poblacional del estudio REGICOR , 2011 .

[8]  D. Fernández-Bergés,et al.  [Cardiovascular risk factors in Spain in the first decade of the 21st Century, a pooled analysis with individual data from 11 population-based studies: the DARIOS study]. , 2011, Revista espanola de cardiologia.

[9]  G. Pera,et al.  El índice tobillo-brazo mejora la clasificación del riesgo cardiovascular: estudio ARTPER/PERART , 2011 .

[10]  R. Brugada,et al.  Derivation and validation of REASON: a risk score identifying candidates to screen for peripheral arterial disease using ankle brachial index. , 2011, Atherosclerosis.

[11]  M. Henriksson,et al.  Asymptomatic peripheral arterial disease: is pharmacological prevention of cardiovascular risk cost-effective? , 2011, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[12]  N. Wareham,et al.  Estimating the population impact of screening strategies for identifying and treating people at high risk of cardiovascular disease: modelling study , 2010, BMJ : British Medical Journal.

[13]  G. Pera,et al.  The Peripheral Arterial disease study (PERART/ARTPER): prevalence and risk factors in the general population , 2010, BMC public health.

[14]  H. Kautiainen,et al.  Ankle–brachial index is lower in hypertensive than in normotensive individuals in a cardiovascular risk population , 2009, Journal of hypertension.

[15]  J Marrugat,et al.  Prevalence of symptomatic and asymptomatic peripheral arterial disease and the value of the ankle-brachial index to stratify cardiovascular risk. , 2009, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[16]  P. Greenland,et al.  Defining a rational approach to screening for cardiovascular risk in asymptomatic patients. , 2008, Journal of the American College of Cardiology.

[17]  A Hofman,et al.  Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis. , 2008, JAMA.

[18]  L. Norgren,et al.  Inter-society consensus for the management of peripheral arterial disease. , 2007, International angiology : a journal of the International Union of Angiology.

[19]  R. Peters,et al.  A clinical prediction model for the presence of peripheral arterial disease — the benefit of screening individuals before initiation of measurement of the ankle—brachial index: an observational study , 2007, Vascular medicine.

[20]  Ralph B D'Agostino,et al.  EVIDENCE BASED PUBLIC HEALTH POLICY AND PRACTICE Validity of an adaptation of the Framingham cardiovascular risk function: the VERIFICA study , 2006 .

[21]  J. Price,et al.  Risk of mortality and cardiovascular disease associated with the ankle-brachial index: Systematic review. , 2006, Atherosclerosis.

[22]  V. Aboyans,et al.  Can we improve cardiovascular risk prediction beyond risk equations in the physician's office? , 2006, Journal of clinical epidemiology.

[23]  John V. White,et al.  ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography , 2006, Circulation.

[24]  N. Perkins,et al.  Optimal Cut-point and Its Corresponding Youden Index to Discriminate Individuals Using Pooled Blood Samples , 2005, Epidemiology.

[25]  M. Chiariello,et al.  Prevalence, risk factors and cardiovascular comorbidity of symptomatic peripheral arterial disease in Italy. , 2004, Atherosclerosis.

[26]  Y. Aso,et al.  Results of blood inflammatory markers are associated more strongly with toe-brachial index than with ankle-brachial index in patients with type 2 diabetes. , 2004, Diabetes care.

[27]  Richard B Devereux,et al.  Relationship of High and Low Ankle Brachial Index to All-Cause and Cardiovascular Disease Mortality: The Strong Heart Study , 2004, Circulation.

[28]  T. Marshall,et al.  Resource implications and health benefits of primary prevention strategies for cardiovascular disease in people aged 30 to 74: mathematical modelling study , 2002, BMJ : British Medical Journal.

[29]  L. Molyneaux,et al.  TBI or not TBI: that is the question. Is it better to measure toe pressure than ankle pressure in diabetic patients? , 2001, Diabetic medicine : a journal of the British Diabetic Association.

[30]  J. Knottnerus,et al.  The prevalence of asymptomatic and unrecognized peripheral arterial occlusive disease. , 1996, International journal of epidemiology.

[31]  F. Fowkes,et al.  The Edinburgh Claudication Questionnaire: an improved version of the WHO/Rose Questionnaire for use in epidemiological surveys. , 1992, Journal of clinical epidemiology.

[32]  R. Langer,et al.  Mortality over a period of 10 years in patients with peripheral arterial disease. , 1992, The New England journal of medicine.

[33]  R. Prescott,et al.  Edinburgh Artery Study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. , 1991, International journal of epidemiology.

[34]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[35]  M. Pencina,et al.  Ankle-brachial index and cardiovascular risk prediction: an analysis of 11,594 individuals with 10-year follow-up. , 2012, Atherosclerosis.

[36]  J. Marrugat,et al.  [Relative validity of the 10-year cardiovascular risk estimate in a population cohort of the REGICOR study]. , 2011, Revista espanola de cardiologia.

[37]  R. Roussel,et al.  Use and utility of ankle brachial index in patients with diabetes. , 2011, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[38]  G. Pera,et al.  Ankle-brachial index improves the classification of cardiovascular risk: PERART/ARTPER Study. , 2011, Revista espanola de cardiologia.

[39]  D. Fernández-Bergés,et al.  Cardiovascular Risk Factors in Spain in the First Decade of the 21 st Century , a Pooled Analysis With Individual Data From 11 Population-Based Studies : the DARIOS Study , 2011 .

[40]  L. Norgren,et al.  Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). , 2007, Journal of vascular surgery.

[41]  Yoram Rudy,et al.  From vulnerable plaque to vulnerable patient--Part III: Executive summary of the Screening for Heart Attack Prevention and Education (SHAPE) Task Force report. , 2006, The American journal of cardiology.

[42]  W. Youden,et al.  Index for rating diagnostic tests , 1950, Cancer.